A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer.
A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer.
复制标题
胞苷脱氨酶抑制剂四氢尿苷联合地西他滨在晚期化疗难治性胰腺癌中靶向 DNMT1 的初步临床试验。
DOI：
--
复制
发表时间：
2020
影响因子：
5.3
通讯作者：
Saunthararajah,Yogen
中科院分区：
文献类型：
--
作者：
Sohal,Davendra;Krishnamurthi,Smitha;Tohme,Rita;Gu,Xiaorong;Lindner,Daniel;Landowski,TerryH;Pink,John;Radivoyevitch,Tomas;Fada,Sherry;Lee,Zhenghong;Shepard,Dale;Khorana,Alok;Saunthararajah,Yogen
